PTEN and breast cancer: PTEN was ablated using CRISPR-Cas9 technology (PTEN_KO) in the ER+ PIK3CAmut breast cancer cell lines T47D (H1047R) and MCF7 (E545K) overexpressing Cas9 (Supplementary Fig. 2A).